Abbott, Others Marketed Stents Off-Label: Suit
Boston Scientific Corp., Abbott Laboratories and Cordis Corp. engaged in an off-label marketing scheme to promote digestive tract stents for unapproved use in other parts of the body, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article